Inflammation and Co-Infections in D ²EFT
Conditions: HIV-infection/Aids; Human Herpesvirus 4 Infections; Cytomegalovirus Infections; Human Herpesvirus 8 Infection; Human Papilloma Virus Interventions: Drug: NRTIs; Drug: Darunavir; Drug: Ritonavir; Drug: Dolutegravir Sponsors: Kirby Institute; Frederick National Laboratory for Cancer Research; UNITAID; National Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare; Janssen Pharmaceutica Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Cancer & Oncology | HIV AIDS | Infectious Diseases | Norvir | Prezista | Research